Literature DB >> 6704727

Convergence-initiated voluntary flutter: a normal intrinsic capability in man.

J R Hotson.   

Abstract

The proposal that there is an inherent capability in humans to produce bursts of fluttering saccades was tested by comparing Purkinje image eye movement recordings in subjects with voluntary nystagmus and control subjects. Voluntary nystagmus is composed of recurrent saccades without an intersaccade interval and has been proposed to be an inherited event. No difference in saccade peak velocity-amplitude curves or microsaccades during visual fixation was found between the two groups. With training control subjects learned to produce runs of saccadic flutter identical to voluntary nystagmus. This learned flutter was composed of recurrent complete saccades rather than saccades interrupted in midflight. Voluntary flutter is thus not a genetic trait but a learned event that is usually undeveloped in man. These observations can be explained by the Robinson model of saccade generation and indicate that similar models must have an inherent ability to produce saccadic flutter.

Entities:  

Mesh:

Year:  1984        PMID: 6704727     DOI: 10.1016/0006-8993(84)91041-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Eye movement tics.

Authors:  F Shawkat; C M Harris; M Jacobs; D Taylor; E M Brett
Journal:  Br J Ophthalmol       Date:  1992-11       Impact factor: 4.638

Review 2.  How to assess eye movements clinically.

Authors:  Caroline Froment Tilikete
Journal:  Neurol Sci       Date:  2022-03-03       Impact factor: 3.830

3.  Voluntary Flutter Presenting During Ophthalmoscopy: A Case Report.

Authors:  Nikita Thomas; Matt J Dunn; J Margaret Woodhouse
Journal:  Case Rep Ophthalmol       Date:  2022-04-22

4.  Ocular oscillations generated by coupling of brainstem excitatory and inhibitory saccadic burst neurons.

Authors:  Stefano Ramat; R John Leigh; David S Zee; Lance M Optican
Journal:  Exp Brain Res       Date:  2005-01       Impact factor: 1.972

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.